New Strains Added

For more added benefits we have added a whole host additional bacteria strains.

Why is this so important ?

Adding additional strains of the same species is important as some strains can do what other strains within the same species can not do.

The bacterial species category defines an organism on the basis of genetic similarity,
biochemical, and phenotypic criteria.

A strain designation reflects descendants of a single organism and are classified based
on unique characteristics defined by serotyping, enzyme typing, protein/nucleic acids/
plasmid characterization, and functional characteristics important to probiotic strains
including: undesirable bacteria inhibition, gastric acid tolerance, adhesion/colonization,
hydrophobicity, immunomodulatory cytokine production, etc.

All Strains are clinically-documented, safe and demonstrates proven efficacy in strengthening gut health.

Blend of bacteria adapted to upper intestine support as well as lower intestine support

LACTOBACILLUS REUTERI

While our product always contained L. reuteri we have have added two specific bacterial strains of L. reuteri used in research.

Studies that experimented with L. reuteri yogurt consumption in animals & humans suggested dramatic health benefits for both. These include the ability to:

  • Improve skin youthfulness, increases collagen & reduces wrinkles
  • Accelerate skin healing
  • Promote thick and shiny hair
  • Increase testosterone levels in men
  • Increase the ‘feel good’ hormone oxytocin
  • Lower stress
  • Reduce acid reflux and infantile colic
  • Suppress H.pylori & C.difficile and protects against intestinal infections
  • Lower pain perception
  • Increase vitamin D3 levels by up to 25.5%
  • Decrease incidences of diarrhoea but also increase bowel frequency
  • Fight candida
  • Prevent and treat small intestinal bacterial overgrowth (SIBO) 
  • Promote thyroid health and oral health
  • Protect against certain infections
  • Reduce insulin resistance
  • Increase muscle mass and bone density
  • Glydo-D contains the two specific bacterial strains, L. reuteri used in this research.

Lactobacillus acidophilus (two strains)

Immunomodulatory function:

  • Regular administration leads to a modulation of the immunological and inflammatory response in elderly subjects
  • an increase in levels of serum IgA and IgM. Immunoglobulin A (IgA, also referred to as sIgA) after vaccinations

Anti-pathogenic:

  • In vitro six strains of L. acidophilus inhibited H. pylori growth due both to the pH of the solution and its concentration.
  • Enhanced phagocytosis of Escherichia coli sp. in vitro after consumption by healthy volunteers

Anti-diarrhoeal:

  • Appeared to prevent radiotherapy-associated diarrhoea
  • Eliminated infantile diarrhoea in 4 days and allowed patients to return to free feeding and restored faecal flora.
  • Prevented diarrhoea from amoxycillin in infancy

Anti-candida:

  • Decreased both candida colonisation and infection in women

Lactose intolerance:

  • Fermented milk significantly influences lactose digestion and minor development of symptoms in lactase-deficient subjects and lengthens significantly the orocecal transit time compared with regular milk.

IBS:

  • 73% improvement in bloating and 62% improvement in pain and cramps
  • significant decrease in levels of the pain perception signalling.
  • is able to reduce pain in the gut by increasing MOR receptor expression 40-fold
  • shown to induce expression of μ-opioid and cannabinoid receptors in intestinal epithelial cells

Lactobacillus bulgaricus

Immunomodulatory function:

  • Improved functional activity of mononuclear phagocytes useful to increase resistance to diverse toxic substances and bacterial infection
  • In vitro beneficial effects on the systemic and mucosal immune system such as induced IgA antibody production by Peyer’s patches
  • Inhibited the growth of intestinal carcinoma through increased activity of IgA, T cells, and macrophages in animals
  • Activated the phagocytic and secretory functions of mononuclear cells and increased host resistance to bacterial infections.
  • Improved mice resistance to S. typhimurium and B. pertussis

Anti-microbial:

  • Reduced mortality to Salmonella typhimurium infection in mice

Anti-diarrhoeal:

  • Less weight loss and higher resolution of persistent infantile diarrhoea

Lactose intolerance:

  • Increased lactase content in fermented milk and significantly reduced symptoms and improved
    digestion of the yogurt

Lactobacillus casei


Immunomodulatory function:

  • Oral administration of Lactobacillus casei stimulated type 1 helper T (Th1) cells, activated thecellular immune system and inhibited incidence of tumors and IgE production.
  • Prevented enteric infections and stimulated secretory IgA in malnourished animals

Anti-microbial:

  • Inhibited adhesion of E. coli to the intestinal mucosa of conventional and gnotobiotic pigs, probably mediated by antibacterial substances and stimulation of immunity
  • Enhanced resistance to systemic infection with Listeria in mice

Anti-diarrhoeal:

  • The mean duration of diarrhoea after commencing the therapy was significantly shorter in 71 well-nourished children between 4 and 45 months of age.
  • Eliminated infantile diarrhoea in 4 days and allowed patients to return to free feeding and restored faecal flora.
  • Significantly decreased severity of acute diarrhoea in healthy children over a 6 month period

Lactose intolerance:

  • Fermented milk significantly influences lactose digestion and minor development of symptoms in lactase-deficient subjects and lengthens significantly the orocecal transit time compared with regular milk.

Antidiabetic:

  • Decreased the plasma glucose level, insulin levels and modified the host immune responses in mice with non-insulin-dependent diabetes mellitus.

Lactobacillus plantarum


Anti-pathogenic:

  • Produces a new two-peptide bacteriocin, which has antimicrobial activity and act synergistically to inhibit a large number of Gram-positive bacteria

Lactobacillus rhamnosus


Immunomodulatory function:

  • Enhanced IL-10 generation in vivo substantiates the anti-inflammatory properties
  • Enhancement of IgA response to rotavirus in children with acute rotavirus gastroenteritis
  • Stimulated rotavirus specific IgA antibody responses, theoretically significant in the prevention of reinfections
  • Showed specific immunomodulatory effects on the proliferative activity of B and T lymphocytes and may also reduce lymphocyte sensitivity to the cytotoxic effects of lectin mitogens.

Anti-microbial:

  • Inhibited adherence of a pathogenic Escherichia coli to intestinal epithelial cells in vitro, possibly through increased intestinal mucins.

Anti-diarrhoeal (AAD):

  • Reduced incidence of diarrhoea in 119 children taking antimicrobials
  • Significant decrease in patient complaints of gastrointestinal side effects and yeast superinfection while taking amoxicillin
  • Shortened diarrhoea phase and significantly influenced bacterial enzyme profile and stoolbacterial count

Lactobacillus helveticus

  • Anti-Microbial
  • Anti-cancerous:
  • Hypertension:

Lactobacillus salivarius

  • Antimicrobial
  • Anti-cancerous
  • Infectious Diseases
  • Urogenital Infections

Lactococcus lactis


Antimicrobial:

  • Identified the production of a novel bacteriocin (antimicrobial peptide)
  • Strongly reduced the occurrence of yeasts and bacteria in voice prosthetic biofilms
  • Produces nisin is an antimicrobial peptide that can be used in food packaging to protect against Salmonella contamination
  • Produced bacteriocin active against some food-borne pathogens including Staphylococcus aureus, Listeria monocytogenes and Salmonella typhimurium
  • Antibacterial activity against Listeria monocytogenes
  • Simultaneously produced both antimicrobial agents pediocin PA-1 and nisin A

Lactobacillus paracasei

  •  improve immune responses
  • reduce duration of cold & flu symptoms by 41%
  • improves Gastrointestinal Function in Children and Adults
  • inhibit the growth of some pathogens including E.Coli, Salmonella typhimurium and Shigella sonnei 

Bacillus subtilis


Immune System:

Enhanced Th1 response

Helped activate innate immunity. Stimulation of antigen-presenting cells and T lymphocytes was also markedly enhanced

Anti-Pathogenic:

Shown to improve drug compliance, reduce side effects and enhance the intention-to-treat
eradication rate of Helicobacter pylori.

Streptococcus thermophilus


Immunomodulatory function:

  • Transient production of interferon induced in healthy subjects after consumption of L. bulgaricus
  • Stimulated macrophage and T-cell cytokine production

Anti-microbial:

  • Produces a bacteriocin that exhibited a bactericidal effect against Listeria monocytogenes
  • Reduced mortality to Salmonella typhimurium infection in mice

Anti-diarrhoeal:

  • Reduced the incidence of acute diarrhoea and rotavirus shedding in infants admitted to hospital.
  • Less weight loss and higher resolution of persistent infantile diarrhoea

Anti-candida

  • Streptococcus thermophilus and its biosurfactants inhibited adhesion by Candida spp

Bifidobacterium bifidum


Anti-cancerous:
Diarrhoea:
Immunomodulatory function:
Infectious Disease:
Irritable Bowel Syndrome:

Bifidobacterium breve


Immunomodulatory function:

  • The oral administration of B. breve significantly decreased rotavirus shedding in stool samples and prevented rotavirus infection
  • Oral administration of Bifidobacterium breve activated the humoral immune system, augmented anti-rotavirus IgA production or anti-influenza virus (IFV) IgG production and protected against rotavirus infection or influenza infection, respectively.
  • The oral administration of B. breve may enhance antigen-specific IgG against various pathogenic antigens taken orally and induce protection against various virus infections.

Bifidobacteria infantis


Immunomodulatory function:

  • Adjuvant activity of the cell wall of Bifidobacterium infantis for in vivo immune responses in mice predict a role as an immunomodulator in human and animal intestines.

Anti-microbial:

  • Able to exert an inhibitory effect on Escherichia coli and Clostridium perfringens not necessarily related to acid production

Bifidobacterium lactis (two strains)

  • supports immune function in children
  • supports immune function in elderly
  • increase in phagocytic activity of both monocytes and granulocytes
  • increased IgG in an early response to the vaccine
  • significantly reduced presence of eosinophils
  • 27% lower incidence of upper respiratory infections
  • supports the balance of intestinal bacteria during and after antibiotic therapy
  • Reduces  diarrhoea caused by antibiotics, or diarrhoea caused by C. difficile infection symptoms and frequency of diarrhoea, as well as for fever, pain and bloating
  • alleviates bloating symptoms
  • Reduction of Atopic dermatitis (AD)

Bifidobacterium longum


Immunomodulatory function:

  • By increasing mucosal IgA response may protect a host from invasion of the intestinal mucosa by dietary antigens that have escaped enzymatic digestion in the intestine.

Anti-microbial:

  • Decreased E.coli translocation
  • Improved the faecal properties such as faecal ammonia concentration and beta-glucuronidase activity.
  • Repeated inoculation decreased and kept down the initial E. coli population

Lactose intolerance:

  • Might reduce breath hydrogen response and symptoms from lactose malabsorption